Loading organizations...
§ Private Profile · Hongo, Tokyo, Japan
Develops and provides digital therapeutic solutions for remote cardiac rehabilitation, specifically designed for home-based patient care.
CaTe is a healthcare technology company developing a digital therapeutic platform designed to facilitate remote cardiac rehabilitation for patients recovering at home. The organization focuses on providing specialized software solutions that allow individuals with cardiovascular conditions to undergo medically supervised recovery programs outside of traditional clinical settings. Operating within the broader digital health and telemedicine sectors, the enterprise aims to address the logistical challenges associated with ongoing cardiac care and patient monitoring. Specific operational metrics, including total funding raised, current valuation figures, active user counts, and total employee headcount, remain undisclosed in public financial databases. Furthermore, details regarding institutional lead investors, strategic corporate partnerships, or major healthcare providers utilizing the platform are not currently available for public review. The exact founding year and the identities of the company's founders have not been publicly disclosed at this time.
CaTe has raised $11.1M across 1 funding round.
CaTe has raised $11.1M in total across 1 funding round.
CaTe has raised $11.1M across 1 funding round. Most recently, it raised $11.1M Series B in December 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 3, 2025 | $11.1M Series B | 井田 修一, Sumitomo Mitsui Trust Bank, Keisuke Omori, Sparx Asset Management | Yuki Yamazaki, Mayumi Beppu, 石原祐太, Samurai Incubate, 川上正衡 | Announced |
CaTe has raised $11.1M in total across 1 funding round.
CaTe's investors include 井田 修一, Sumitomo Mitsui Trust Bank, Keisuke Omori, SPARX Asset Management, Yuki Yamazaki, Mayumi Beppu, 石原祐太, Samurai Incubate, 川上正衡.